| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K13185470 | CTRPv2 | pan-cancer | AAC | -0.087 | 0.2 |
| mRNA | AT-7519 | GDSC1000 | pan-cancer | AAC | 0.038 | 0.2 |
| mRNA | Gefitinib | CTRPv2 | pan-cancer | AAC | 0.046 | 0.2 |
| mRNA | EHT 1864 | GDSC1000 | pan-cancer | AAC | -0.044 | 0.2 |
| mRNA | paclitaxel | GDSC1000 | pan-cancer | AAC | 0.065 | 0.2 |
| mRNA | GDC-0449 | GDSC1000 | pan-cancer | AAC | 0.046 | 0.2 |
| mRNA | DMOG | GDSC1000 | pan-cancer | AAC | -0.042 | 0.2 |
| mRNA | navitoclax:birinapant (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.045 | 0.2 |
| mRNA | BMS-195614 | CTRPv2 | pan-cancer | AAC | -0.048 | 0.2 |
| mRNA | Crizotinib | FIMM | pan-cancer | AAC | -0.21 | 0.2 |